Valuation DexCom, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-02 EDT			5-day change	1st Jan Change
85.36 ^USD	-1.01%		-1.45%	+28.61%

10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-28	Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	52,042	43,740	47,945	30,377	25,885	32,212	-	-
Change	-	-15.95%	9.61%	-36.64%	-14.79%	24.44%	-	-
Enterprise Value (EV) ¹	52,692	45,068	49,813	31,073	26,209	31,450	31,150	30,335
Change	-	-14.47%	10.53%	-37.62%	-15.65%	20%	-0.95%	-2.62%
P/E	346x	138x	95.5x	54.8x	31.8x	34.3x	28.9x	24x
PBR	23.1x	20.5x	23.1x	15.1x	9.3x	11.3x	9.45x	7.27x
PEG	-	1x	1.6x	5.94x	0.7x	1.8x	1.6x	1.2x
Capitalization / Revenue	21.3x	15x	13.2x	7.53x	5.55x	6.16x	5.55x	4.99x
EV / Revenue	21.5x	15.5x	13.8x	7.7x	5.62x	6.01x	5.37x	4.7x
EV / EBITDA	111x	60x	49.1x	28.1x	19.4x	18.9x	16.2x	13.7x
EV / EBIT	142x	92.9x	69.3x	41x	27x	25.2x	21.5x	17.6x
EV / FCF	989x	148x	97.3x	49.3x	24.3x	30.8x	25.5x	20.6x
FCF Yield	0.1%	0.68%	1.03%	2.03%	4.11%	3.25%	3.92%	4.84%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.3875	0.82	1.3	1.42	2.09	2.489	2.952	3.562
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,448	2,910	3,622	4,033	4,662	5,230	5,800	6,461
EBITDA ¹	472.7	751.6	1,014	1,105	1,349	1,667	1,921	2,218
EBIT ¹	370.7	485.1	718.6	757.1	969.3	1,248	1,446	1,719
Net income ¹	154.7	341.2	541.5	576.2	836.3	974.4	1,149	1,409
Net Debt ¹	650.1	1,328	1,868	695.9	323.2	-761.1	-1,061	-1,877
Reference price ²	134.24	113.24	124.09	77.77	66.37	85.36	85.36	85.36
Nbr of stocks (in thousands)	387,688	386,258	386,374	390,595	390,016	377,361	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/13/25	2/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DEXCOM, INC.	34.3x	6.01x	18.87x	-.--%	32.21B
ABBOTT LABORATORIES	27.63x	3.84x	14.83x	2.64%	169B
MEDTRONIC PLC	18.25x	3.37x	12.04x	3.26%	110B
STRYKER CORPORATION	21.42x	4.21x	14.72x	1.31%	106B
ESSILORLUXOTTICA	25.26x	2.48x	10.04x	2.86%	73.87B
CENCORA, INC.	16.92x	0.2x	12.42x	0.77%	58.98B
HOYA CORPORATION	29.48x	7.29x	18.84x	1.36%	51.28B
BECTON, DICKINSON AND COMPANY	34.07x	3.32x	11.38x	2.22%	48.16B
IDEXX LABORATORIES, INC.	35.11x	8.73x	24.55x	-.--%	40.84B
ALCON INC.	36.95x	3.01x	11.26x	0.58%	30.8B
Average	27.94x	4.25x	14.89x	1.5%	72.1B
Weighted average by Cap.	25.84x	3.93x	14.33x	1.93%